img

Global PD-L1 Inhibitors Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PD-L1 Inhibitors Market Insights, Forecast to 2034

PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs
Global PD-L1 Inhibitors market is expected to reach to US$ 8483.3 million in 2024, with a positive growth of %, compared with US$ 8139 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, PD-L1 Inhibitors industry is evaluated to reach US$ 11170 million in 2029. The CAGR will be 4.7% during 2024 to 2029.
The PD-1 and PD-L1 Inhibitor market is driven by the increasing demand for advanced immunotherapy options in oncology. PD-1 and PD-L1 inhibitors are revolutionary treatments that block specific proteins, enhancing the immune system's ability to recognize and attack cancer cells. The growing prevalence of various cancers, coupled with the need for targeted therapies that offer improved efficacy and fewer side effects compared to traditional treatments, contributes to market growth. Additionally, the expanding list of approved indications for these inhibitors, such as melanoma, lung cancer, and more, further propels adoption. However, challenges include managing potential immune-related adverse events and identifying patients who are most likely to respond to these treatments. Navigating the complex landscape of combination therapies and addressing access and affordability barriers for a broader patient population are ongoing concerns. The market's success relies on continuous research to optimize treatment regimens and identify biomarkers for patient selection, comprehensive patient education about the potential benefits and risks, and collaborations between pharmaceutical companies, healthcare providers, and research institutions to advance cancer treatment while addressing the evolving challenges associated with PD-1 and PD-L1 inhibitor therapy.
Report Covers
This report presents an overview of global PD-L1 Inhibitors market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global PD-L1 Inhibitors market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
AstraZeneca
Merck KGaA
Segment by Type
TECENTRIQ
Imfinzi
Bavencio

Segment by Application


Retail Pharmacy
Hospital Pharmacy
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ PD-L1 Inhibitors plant distribution, commercial date of PD-L1 Inhibitors, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, PD-L1 Inhibitors introduction, etc. PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of PD-L1 Inhibitors
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 PD-L1 Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global PD-L1 Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 TECENTRIQ
1.2.3 Imfinzi
1.2.4 Bavencio
1.3 Market by Application
1.3.1 Global PD-L1 Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PD-L1 Inhibitors Sales Estimates and Forecasts 2018-2029
2.2 Global PD-L1 Inhibitors Revenue by Region
2.2.1 Global PD-L1 Inhibitors Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global PD-L1 Inhibitors Revenue by Region (2018-2024)
2.2.3 Global PD-L1 Inhibitors Revenue by Region (2024-2029)
2.2.4 Global PD-L1 Inhibitors Revenue Market Share by Region (2018-2029)
2.3 Global PD-L1 Inhibitors Sales Estimates and Forecasts 2018-2029
2.4 Global PD-L1 Inhibitors Sales by Region
2.4.1 Global PD-L1 Inhibitors Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global PD-L1 Inhibitors Sales by Region (2018-2024)
2.4.3 Global PD-L1 Inhibitors Sales by Region (2024-2029)
2.4.4 Global PD-L1 Inhibitors Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global PD-L1 Inhibitors Sales by Manufacturers
3.1.1 Global PD-L1 Inhibitors Sales by Manufacturers (2018-2024)
3.1.2 Global PD-L1 Inhibitors Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PD-L1 Inhibitors in 2022
3.2 Global PD-L1 Inhibitors Revenue by Manufacturers
3.2.1 Global PD-L1 Inhibitors Revenue by Manufacturers (2018-2024)
3.2.2 Global PD-L1 Inhibitors Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by PD-L1 Inhibitors Revenue in 2022
3.3 Global Key Players of PD-L1 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global PD-L1 Inhibitors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of PD-L1 Inhibitors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of PD-L1 Inhibitors, Product Offered and Application
3.8 Global Key Manufacturers of PD-L1 Inhibitors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global PD-L1 Inhibitors Sales by Type
4.1.1 Global PD-L1 Inhibitors Historical Sales by Type (2018-2024)
4.1.2 Global PD-L1 Inhibitors Forecasted Sales by Type (2024-2029)
4.1.3 Global PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
4.2 Global PD-L1 Inhibitors Revenue by Type
4.2.1 Global PD-L1 Inhibitors Historical Revenue by Type (2018-2024)
4.2.2 Global PD-L1 Inhibitors Forecasted Revenue by Type (2024-2029)
4.2.3 Global PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
4.3 Global PD-L1 Inhibitors Price by Type
4.3.1 Global PD-L1 Inhibitors Price by Type (2018-2024)
4.3.2 Global PD-L1 Inhibitors Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global PD-L1 Inhibitors Sales by Application
5.1.1 Global PD-L1 Inhibitors Historical Sales by Application (2018-2024)
5.1.2 Global PD-L1 Inhibitors Forecasted Sales by Application (2024-2029)
5.1.3 Global PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
5.2 Global PD-L1 Inhibitors Revenue by Application
5.2.1 Global PD-L1 Inhibitors Historical Revenue by Application (2018-2024)
5.2.2 Global PD-L1 Inhibitors Forecasted Revenue by Application (2024-2029)
5.2.3 Global PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
5.3 Global PD-L1 Inhibitors Price by Application
5.3.1 Global PD-L1 Inhibitors Price by Application (2018-2024)
5.3.2 Global PD-L1 Inhibitors Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada PD-L1 Inhibitors Market Size by Type
6.1.1 US & Canada PD-L1 Inhibitors Sales by Type (2018-2029)
6.1.2 US & Canada PD-L1 Inhibitors Revenue by Type (2018-2029)
6.2 US & Canada PD-L1 Inhibitors Market Size by Application
6.2.1 US & Canada PD-L1 Inhibitors Sales by Application (2018-2029)
6.2.2 US & Canada PD-L1 Inhibitors Revenue by Application (2018-2029)
6.3 US & Canada PD-L1 Inhibitors Market Size by Country
6.3.1 US & Canada PD-L1 Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada PD-L1 Inhibitors Sales by Country (2018-2029)
6.3.3 US & Canada PD-L1 Inhibitors Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe PD-L1 Inhibitors Market Size by Type
7.1.1 Europe PD-L1 Inhibitors Sales by Type (2018-2029)
7.1.2 Europe PD-L1 Inhibitors Revenue by Type (2018-2029)
7.2 Europe PD-L1 Inhibitors Market Size by Application
7.2.1 Europe PD-L1 Inhibitors Sales by Application (2018-2029)
7.2.2 Europe PD-L1 Inhibitors Revenue by Application (2018-2029)
7.3 Europe PD-L1 Inhibitors Market Size by Country
7.3.1 Europe PD-L1 Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe PD-L1 Inhibitors Sales by Country (2018-2029)
7.3.3 Europe PD-L1 Inhibitors Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China PD-L1 Inhibitors Market Size
8.1.1 China PD-L1 Inhibitors Sales (2018-2029)
8.1.2 China PD-L1 Inhibitors Revenue (2018-2029)
8.2 China PD-L1 Inhibitors Market Size by Application
8.2.1 China PD-L1 Inhibitors Sales by Application (2018-2029)
8.2.2 China PD-L1 Inhibitors Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia PD-L1 Inhibitors Market Size by Type
9.1.1 Asia PD-L1 Inhibitors Sales by Type (2018-2029)
9.1.2 Asia PD-L1 Inhibitors Revenue by Type (2018-2029)
9.2 Asia PD-L1 Inhibitors Market Size by Application
9.2.1 Asia PD-L1 Inhibitors Sales by Application (2018-2029)
9.2.2 Asia PD-L1 Inhibitors Revenue by Application (2018-2029)
9.3 Asia PD-L1 Inhibitors Sales by Region
9.3.1 Asia PD-L1 Inhibitors Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia PD-L1 Inhibitors Revenue by Region (2018-2029)
9.3.3 Asia PD-L1 Inhibitors Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America PD-L1 Inhibitors Market Size by Type
10.1.1 Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America PD-L1 Inhibitors Market Size by Application
10.2.1 Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Country
10.3.1 Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche PD-L1 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Roche PD-L1 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca PD-L1 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca PD-L1 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Overview
11.3.3 Merck KGaA PD-L1 Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck KGaA PD-L1 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck KGaA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 PD-L1 Inhibitors Industry Chain Analysis
12.2 PD-L1 Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PD-L1 Inhibitors Production Mode & Process
12.4 PD-L1 Inhibitors Sales and Marketing
12.4.1 PD-L1 Inhibitors Sales Channels
12.4.2 PD-L1 Inhibitors Distributors
12.5 PD-L1 Inhibitors Customers
13 Market Dynamics
13.1 PD-L1 Inhibitors Industry Trends
13.2 PD-L1 Inhibitors Market Drivers
13.3 PD-L1 Inhibitors Market Challenges
13.4 PD-L1 Inhibitors Market Restraints
14 Key Findings in The Global PD-L1 Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global PD-L1 Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of TECENTRIQ
Table 3. Major Manufacturers of Imfinzi
Table 4. Major Manufacturers of Bavencio
Table 5. Global PD-L1 Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global PD-L1 Inhibitors Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global PD-L1 Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global PD-L1 Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global PD-L1 Inhibitors Revenue Market Share by Region (2018-2024)
Table 10. Global PD-L1 Inhibitors Revenue Market Share by Region (2024-2029)
Table 11. Global PD-L1 Inhibitors Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global PD-L1 Inhibitors Sales by Region (2018-2024) & (K Units)
Table 13. Global PD-L1 Inhibitors Sales by Region (2024-2029) & (K Units)
Table 14. Global PD-L1 Inhibitors Sales Market Share by Region (2018-2024)
Table 15. Global PD-L1 Inhibitors Sales Market Share by Region (2024-2029)
Table 16. Global PD-L1 Inhibitors Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global PD-L1 Inhibitors Sales Share by Manufacturers (2018-2024)
Table 18. Global PD-L1 Inhibitors Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global PD-L1 Inhibitors Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of PD-L1 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. PD-L1 Inhibitors Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global PD-L1 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Inhibitors as of 2022)
Table 24. Global Key Manufacturers of PD-L1 Inhibitors, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of PD-L1 Inhibitors, Product Offered and Application
Table 26. Global Key Manufacturers of PD-L1 Inhibitors, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 29. Global PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 30. Global PD-L1 Inhibitors Sales Share by Type (2018-2024)
Table 31. Global PD-L1 Inhibitors Sales Share by Type (2024-2029)
Table 32. Global PD-L1 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global PD-L1 Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global PD-L1 Inhibitors Revenue Share by Type (2018-2024)
Table 35. Global PD-L1 Inhibitors Revenue Share by Type (2024-2029)
Table 36. PD-L1 Inhibitors Price by Type (2018-2024) & (US$/Unit)
Table 37. Global PD-L1 Inhibitors Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 39. Global PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 40. Global PD-L1 Inhibitors Sales Share by Application (2018-2024)
Table 41. Global PD-L1 Inhibitors Sales Share by Application (2024-2029)
Table 42. Global PD-L1 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global PD-L1 Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global PD-L1 Inhibitors Revenue Share by Application (2018-2024)
Table 45. Global PD-L1 Inhibitors Revenue Share by Application (2024-2029)
Table 46. PD-L1 Inhibitors Price by Application (2018-2024) & (US$/Unit)
Table 47. Global PD-L1 Inhibitors Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada PD-L1 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada PD-L1 Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada PD-L1 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada PD-L1 Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada PD-L1 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada PD-L1 Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada PD-L1 Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 61. Europe PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 62. Europe PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 63. Europe PD-L1 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe PD-L1 Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 66. Europe PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 67. Europe PD-L1 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe PD-L1 Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe PD-L1 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe PD-L1 Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe PD-L1 Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 73. Europe PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 74. China PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 75. China PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 76. China PD-L1 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 77. China PD-L1 Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 78. China PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 79. China PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 80. China PD-L1 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 81. China PD-L1 Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 83. Asia PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 84. Asia PD-L1 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia PD-L1 Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 87. Asia PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 88. Asia PD-L1 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia PD-L1 Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia PD-L1 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia PD-L1 Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia PD-L1 Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia PD-L1 Inhibitors Sales by Region (2018-2024) & (K Units)
Table 94. Asia PD-L1 Inhibitors Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America PD-L1 Inhibitors Sales by Country (2024-2029) & (K Units)
Table 108. Roche Company Information
Table 109. Roche Description and Major Businesses
Table 110. Roche PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Roche PD-L1 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Roche Recent Developments
Table 113. AstraZeneca Company Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. AstraZeneca PD-L1 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. AstraZeneca Recent Developments
Table 118. Merck KGaA Company Information
Table 119. Merck KGaA Description and Major Businesses
Table 120. Merck KGaA PD-L1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Merck KGaA PD-L1 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Merck KGaA Recent Developments
Table 123. Key Raw Materials Lists
Table 124. Raw Materials Key Suppliers Lists
Table 125. PD-L1 Inhibitors Distributors List
Table 126. PD-L1 Inhibitors Customers List
Table 127. PD-L1 Inhibitors Market Trends
Table 128. PD-L1 Inhibitors Market Drivers
Table 129. PD-L1 Inhibitors Market Challenges
Table 130. PD-L1 Inhibitors Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-L1 Inhibitors Product Picture
Figure 2. Global PD-L1 Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global PD-L1 Inhibitors Market Share by Type in 2022 & 2029
Figure 4. TECENTRIQ Product Picture
Figure 5. Imfinzi Product Picture
Figure 6. Bavencio Product Picture
Figure 7. Global PD-L1 Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global PD-L1 Inhibitors Market Share by Application in 2022 & 2029
Figure 9. Retail Pharmacy
Figure 10. Hospital Pharmacy
Figure 11. Other
Figure 12. PD-L1 Inhibitors Report Years Considered
Figure 13. Global PD-L1 Inhibitors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global PD-L1 Inhibitors Revenue 2018-2029 (US$ Million)
Figure 15. Global PD-L1 Inhibitors Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global PD-L1 Inhibitors Revenue Market Share by Region (2018-2029)
Figure 17. Global PD-L1 Inhibitors Sales 2018-2029 ((K Units)
Figure 18. Global PD-L1 Inhibitors Sales Market Share by Region (2018-2029)
Figure 19. US & Canada PD-L1 Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada PD-L1 Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe PD-L1 Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 22. Europe PD-L1 Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China PD-L1 Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 24. China PD-L1 Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) PD-L1 Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) PD-L1 Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America PD-L1 Inhibitors Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The PD-L1 Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of PD-L1 Inhibitors in the World: Market Share by PD-L1 Inhibitors Revenue in 2022
Figure 31. Global PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
Figure 33. Global PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
Figure 34. Global PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
Figure 35. Global PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
Figure 37. US & Canada PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
Figure 39. US & Canada PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada PD-L1 Inhibitors Revenue Share by Country (2018-2029)
Figure 41. US & Canada PD-L1 Inhibitors Sales Share by Country (2018-2029)
Figure 42. U.S. PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 43. Canada PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 44. Europe PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
Figure 45. Europe PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
Figure 46. Europe PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
Figure 47. Europe PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
Figure 48. Europe PD-L1 Inhibitors Revenue Share by Country (2018-2029)
Figure 49. Europe PD-L1 Inhibitors Sales Share by Country (2018-2029)
Figure 50. Germany PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 51. France PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 53. Italy PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 54. Russia PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 55. China PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
Figure 56. China PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
Figure 57. China PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
Figure 58. China PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
Figure 59. Asia PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
Figure 60. Asia PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
Figure 61. Asia PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
Figure 62. Asia PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
Figure 63. Asia PD-L1 Inhibitors Revenue Share by Region (2018-2029)
Figure 64. Asia PD-L1 Inhibitors Sales Share by Region (2018-2029)
Figure 65. Japan PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 69. India PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America PD-L1 Inhibitors Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America PD-L1 Inhibitors Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America PD-L1 Inhibitors Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America PD-L1 Inhibitors Sales Share by Country (2018-2029)
Figure 76. Brazil PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 79. Israel PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries PD-L1 Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 81. PD-L1 Inhibitors Value Chain
Figure 82. PD-L1 Inhibitors Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries